Document is current

Article History

Received: 5 December 2022

Accepted: 19 January 2023

First Online: 7 February 2023

Declarations

:

: This study conforms to the ethical guidelines of the Declaration of Helsinki revised in 2013 and was approved by the Institutional Review Board of Seoul National University Hospital (No. H-2206-204-1335). Informed consent was waived because the study was retrospective and only used anonymized data.

: Not applicable.

: Kwon S, Lee SR, Oh S: None to disclose. Choi EK: Research grants or speaking fees from Abbott, Bayer, BMS/Pfizer, Biosense Webster, Chong Kun Dang, Daewoong Pharmaceutical Co., Daiichi-Sankyo, DeepQure, Dreamtech Co., Ltd., Jeil Pharmaceutical Co. Ltd, Medtronic, Samjinpharm, Seers Technology, and Skylabs. Stock options from Seers Technology, and Skylabs.